Our process
Every year we carefully invest a proportion of our income into our research. Underpinning the research is our commitment to the highest standards; as part of this we have set policies to govern our research.
Read about our Research Strategy
Read our Research Governance and Integrity Policy
We do not fund research involving animals; however, we do understand the importance of it. Read about our policy on animal testing
Expert review process
To be sure the research we fund aligns with our organisational and research aims, and has the highest possible impact, Anthony Nolan has established a Research Review Board (RRB) to review and discuss all Anthony Nolan funded research projects. This includes exciting new research proposals, as well as long-term projects that have been running for more than 5 years. The RRB consists of a panel of medical professionals and experts in the fields of our research as well as donor and patient advocates. The focus of the RRB members is to provide a recommendation on the suitability of proposed or long-term research, considering the following factors (defined further in the RRB Terms of Reference):
- Alignment with Anthony Nolan’s Research Strategy
- Quality of the research
- Feasibility/appropriateness of resources
- Likelihood to generate future impact
The expert review process and the RRB are coordinated by the Research Office and meets the principles of expert review as outlined by the Association of Medical Research Charities (AMRC). If you would like more information, please contact the Research Office.
Independent Research Organisation status
In November 2020 Anthony Nolan was awarded Independent Research Organisation status by UK Research and innovation. As a result, we can now apply directly to the UK Research Councils for funding. This will enable us to increase our research capability, both in terms of our scientific workforce and the resources we can provide for them.
It’s the next step in our ambition to strengthen our collaboration with other academics and embed research excellence at the heart of all our activities. This means our research will have a greater impact and accelerate the rate at which new treatments are developed for our patients.